275 related articles for article (PubMed ID: 21706056)
1. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.
Bulut G; Hong SH; Chen K; Beauchamp EM; Rahim S; Kosturko GW; Glasgow E; Dakshanamurthy S; Lee HS; Daar I; Toretsky JA; Khanna C; Uren A
Oncogene; 2012 Jan; 31(3):269-81. PubMed ID: 21706056
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.
Çelik H; Hong SH; Colón-López DD; Han J; Kont YS; Minas TZ; Swift M; Paige M; Glasgow E; Toretsky JA; Bosch J; Üren A
Mol Cancer Ther; 2015 Nov; 14(11):2497-507. PubMed ID: 26358752
[TBL] [Abstract][Full Text] [Related]
3. Ezrin Inhibition Up-regulates Stress Response Gene Expression.
Çelik H; Bulut G; Han J; Graham GT; Minas TZ; Conn EJ; Hong SH; Pauly GT; Hayran M; Li X; Özdemirli M; Ayhan A; Rudek MA; Toretsky JA; Üren A
J Biol Chem; 2016 Jun; 291(25):13257-70. PubMed ID: 27137931
[TBL] [Abstract][Full Text] [Related]
4. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
5. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.
Çelik H; Sajwan KP; Selvanathan SP; Marsh BJ; Pai AV; Kont YS; Han J; Minas TZ; Rahim S; Erkizan HV; Toretsky JA; Üren A
Mol Cell Biol; 2015 Sep; 35(18):3145-62. PubMed ID: 26149384
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
Lipreri da Silva JC; Coelho-Silva JL; Lima K; Vicari HP; Lazarini M; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2021 Oct; 44(5):1105-1117. PubMed ID: 34196912
[TBL] [Abstract][Full Text] [Related]
7. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.
Paige M; Kosturko G; Bulut G; Miessau M; Rahim S; Toretsky JA; Brown ML; Üren A
Bioorg Med Chem; 2014 Jan; 22(1):478-87. PubMed ID: 24326277
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis and Motility in Human Neutrophils is Competent but Compromised by Pharmacological Inhibition of Ezrin Phosphorylation.
Roberts RE; Elumalai GL; Hallett MB
Curr Mol Pharmacol; 2018; 11(4):305-315. PubMed ID: 29766831
[TBL] [Abstract][Full Text] [Related]
10. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.
Zhang J; Zuo J; Lei M; Wu S; Zang X; Zhang C
Chin Med J (Engl); 2014; 127(10):1954-9. PubMed ID: 24824262
[TBL] [Abstract][Full Text] [Related]
11. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
12. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.
Zhao H; Guo M; Zhao G; Ma Q; Ma B; Qiu X; Fan Q
Int J Mol Med; 2012 Nov; 30(5):1013-20. PubMed ID: 22922800
[TBL] [Abstract][Full Text] [Related]
13. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
14. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ezrin phosphorylation by NSC305787 attenuates procaterol-stimulated ciliary beating in airway cilia.
Kawaguchi K; Yokoyama S; Wang H; Asano S
Biochem Biophys Res Commun; 2024 Apr; 703():149685. PubMed ID: 38373381
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
18. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells.
Wu B; Li J; Huang D; Wang W; Chen Y; Liao Y; Tang X; Xie H; Tang F
BMC Cancer; 2011 Dec; 11():527. PubMed ID: 22204275
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.
Ren L; Hong SH; Chen QR; Briggs J; Cassavaugh J; Srinivasan S; Lizardo MM; Mendoza A; Xia AY; Avadhani N; Khan J; Khanna C
Cancer Res; 2012 Feb; 72(4):1001-12. PubMed ID: 22147261
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
